[1]Hajjar I, Schumpert J, Hirth V,et al. The impact of the use of
statins on the prevalence of dementia and the progression of
cognitive impairment[J].J Gerontol A Biol Sci Med Sci,
2002,57(7):M414–M418.
[2] Jick H, Zornberg GL, Jick SS,et al. Statins and the risk of de?
mentia[J].Lancet,2000,356(9242):1627-1631.
[3]Rockwood K, Kirkland S, Hogan DB,et al. Use of lipid-low?
ering agents, indication bias, and the risk of dementia in com?
munity-dwelling elderly people[J].Arch Neurol,2002,59
(2):223–227.
[4]Steenland K, Zhao L, Goldstein FC,et al. Statins and cogni?
tive decline in older adults with normal cognition or mild cogni?
tive impairment [J].J Am Geriatr Soc,2013,61(9):1449–
1455.
[5]Redelmeier DA, Thiruchelvam D, Daneman N. Delirium after
elective surgery among elderly patients taking statins[J].
CMAJ,2008,179(7):645–652.
[6]Glasser SP, Wadley V, Judd S,et al.The association of statin
use and statin type and cognitive performance: analysis of the
reasons for geographic and racial differences in stroke (RE?
GARDS)study[J].Clin Cardiol,2010,33(5):280–288.
[7]Muldoon MF, Barger SD, Ryan CM,et al. Effects of lovas?
tatin on cognitive function and psychological well-being [J].
Am J Med,2000,108(7):538–546.
[8]Muldoon MF, Ryan CM, Sereika SM,et al. Randomized trial
of the effects of simvastatin on cognitive functioning in hyper?
cholesterolemic adults[J].Am J Med,2004,117(11):823–
829.
[9]Saher G, Simons M. Cholesterol and myelin biogenesis[J].
SubcellBiochem,2010,51:489–508.
[10]McGuinness B, O’Hare J, Craig D,et al.Cochrane review
on‘Statins for the treatment of dementia’[J].Int J Geriatr
Psychiatry,2013,28(2):119–126.
[11]Miron VE, Zehntner SP, Kuhlmann T,et al.Statin therapy in?
hibits remyelination in the central nervous system [J].Am J
Pathol,2009,174(5):1880–1890.
[12]Klopfleisch S, Merkler D, Schmitz M,et al. Negative impact
of statins on oligodendrocytes and myelin formation in vitro and
in vivo[J].J Neurosci,2008,28(50):13609–13614.